Advertisement
LONDON, Jan. 11, 2018 /PRNewswire/ -- Download the full report: https://www.reportbuyer.com/product/4205660
In addition, demand for personalized or patient centric devices and preventing the needle stick injury provide opportunity for the market. However, blood sugar control is the most challenging aspect as well as security concern and high costs of smart pens are restraining the market growth. Based on type, Bluetooth connected smart insulin pens logs injected insulin doses directly to the patient's digital blood glucose through the Bluetooth wireless interface. The software records each dose accurately and transfers readings into MRAM, and waits for activation of the Bluetooth Smart radio. If, the insulin delivery data doesn't transfer to the phone then, it's stored in the pen, gets ready for the next attempt as soon as the capacitor is recharged. Bluetooth Smart SoC is a unique and effective concept for insulin delivery pens. The pen has combination with other electronic tools, which can lead to glucose control accessible and affordable, which in turn assists in reducing complications and helps patients lead longer lives. BULE (or Bluetooth Smart) technology provides secure 128 bit encrypted data transfer capabilities. North America dominated the smart insulin pens market owing to high persistence of obsolete syringe technology and rising prevalence of diabetes. However, Asia Pacific is the fastest growing market due to increase in prevalence with age and provides new treatment opportunities. Some of the key players in the Global Smart Insulin Pens market are Companion Medical Inc, Digital Medics Ptd Ltd, Eli Lilly and Company, Novo Nordisk A/S, DIAMESCO, Roche, Insulet, Cardiocomm Solutions, BioSampling, Megasan Medical, Emperra GmbH E-Health Technologies, Nipro, Jiangsu Delfu medical device Co.,Ltd and Sanofi Diabetes. Usabilities Covered:
• Reusable Pens • Pre-Filled Pens Indications Covered:
• Diabetes Type I • Diabetes Type II Types Covered:
• Second Generation Pens o USB connected pens o Bluetooth-enabled pens • First Generation Pens Distribution Channels Covered:
• Ambulatory Surgical Centers • Home Care Settings • Hospitals & Clinics • Retail Pharmacies • e-Commerce Fabrications Covered:
• Plastic • Metal Technologies Covered:
• Bluetooth • Jet Injectors • Spring loaded Regions Covered:
• North America
o US o Canada
o Mexico
• Europe
o Germany
o UK o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country level segments - Market share analysis of the top industry players - Strategic recommendations for the new entrants - Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets - Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) - Strategic recommendations in key business segments based on the market estimations - Competitive landscaping mapping the key common trends - Company profiling with detailed strategies, financials, and recent developments - Supply chain trends mapping the latest technological advancementsDownload the full report: https://www.reportbuyer.com/product/4205660
About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers For more information: Sarah Smith
Research Advisor at Reportbuyer.com Email: [email protected] Tel: +1 (646) 453 6293 Website: www.reportbuyer.com
Advertisement
View original content:http://www.prnewswire.com/news-releases/the-global-smart-insulin-pens-market-is-accounted-for-58-million-in-2016-and-expected-to-grow-at-a-cagr-of-122-to-reach-130-million-by-2023-300581614.html
SOURCE ReportBuyer
